Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 
RMJ. 2020; 45(1): 123-126


Platelet-rich plasma in the treatment of chronic plantar fasciitis

Adeel Ahmed Siddiqui, Uzair Yaqoob, Mariyam Adeel.

Abstract
Objective: To evaluate the effect of local platelet-rich plasma (PRP) in the treatment of plantar fasciitis.
Methodology: This study was conducted at Dr. Ruth K. M. Pfau Civil Hospital, Karachi, Pakistan, from September 2018 to March 2019 and included 41 patients. Pain was assessed by using a visual analog scale (VAS) and the overall clinical and functional outcome was assessed by American Orthopedic Foot and Ankle Society (AOFAS) Ankle and Hindfoot score before and after PRP administration.
Results: The mean VAS score after PRP administration decreased from 7.242.01 to 2.780.61 at the final follow-up. The mean AOFAS score improved from 53.567.11 to 86.2411.21 at the final follow-up.
Conclusion: PRP was effective in reversing pain and improving functionality. However, because of this being a single center study, with a limited number of patients, a large-scale study is needed to further authenticate the use of PRP in plantar fasciitis.

Key words: Platelet-rich plasma, plantar fasciitis, visual analog scale, American orthopedic foot and ankle society scale.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Adeel Ahmed Siddiqui
Articles by Uzair Yaqoob
Articles by Mariyam Adeel
on Google
on Google Scholar
Article Statistics
 Viewed: 303
Downloaded: 2


How to Cite this Article
Pubmed Style

Siddiqui AA, Yaqoob U, Adeel M. Platelet-rich plasma in the treatment of chronic plantar fasciitis. RMJ. 2020; 45(1): 123-126.


Web Style

Siddiqui AA, Yaqoob U, Adeel M. Platelet-rich plasma in the treatment of chronic plantar fasciitis. http://www.rmj.org.pk/?mno=75864 [Access: March 29, 2020].


AMA (American Medical Association) Style

Siddiqui AA, Yaqoob U, Adeel M. Platelet-rich plasma in the treatment of chronic plantar fasciitis. RMJ. 2020; 45(1): 123-126.



Vancouver/ICMJE Style

Siddiqui AA, Yaqoob U, Adeel M. Platelet-rich plasma in the treatment of chronic plantar fasciitis. RMJ. (2020), [cited March 29, 2020]; 45(1): 123-126.



Harvard Style

Siddiqui, A. A., Yaqoob, . U. & Adeel, . M. (2020) Platelet-rich plasma in the treatment of chronic plantar fasciitis. RMJ, 45 (1), 123-126.



Turabian Style

Siddiqui, Adeel Ahmed, Uzair Yaqoob, and Mariyam Adeel. 2020. Platelet-rich plasma in the treatment of chronic plantar fasciitis. Rawal Medical Journal, 45 (1), 123-126.



Chicago Style

Siddiqui, Adeel Ahmed, Uzair Yaqoob, and Mariyam Adeel. "Platelet-rich plasma in the treatment of chronic plantar fasciitis." Rawal Medical Journal 45 (2020), 123-126.



MLA (The Modern Language Association) Style

Siddiqui, Adeel Ahmed, Uzair Yaqoob, and Mariyam Adeel. "Platelet-rich plasma in the treatment of chronic plantar fasciitis." Rawal Medical Journal 45.1 (2020), 123-126. Print.



APA (American Psychological Association) Style

Siddiqui, A. A., Yaqoob, . U. & Adeel, . M. (2020) Platelet-rich plasma in the treatment of chronic plantar fasciitis. Rawal Medical Journal, 45 (1), 123-126.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED and Scopus

  Approved by the Higher Education Commission of Pakistan and Pakistan Medical and Dental Council


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.